MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $16.72 million. The enterprise value is $13.88 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MIRA has 16.81 million shares outstanding. The number of shares has increased by 10.91% in one year.
Current Share Class | 16.81M |
Shares Outstanding | 16.81M |
Shares Change (YoY) | +10.91% |
Shares Change (QoQ) | +9.88% |
Owned by Insiders (%) | 14.92% |
Owned by Institutions (%) | 6.98% |
Float | 11.76M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 7.48 |
P/TBV Ratio | 7.60 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.99
Current Ratio | 3.99 |
Quick Ratio | 3.92 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -238.90% and return on invested capital (ROIC) is -152.34%.
Return on Equity (ROE) | -238.90% |
Return on Assets (ROA) | -127.59% |
Return on Invested Capital (ROIC) | -152.34% |
Return on Capital Employed (ROCE) | -364.51% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.62M |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.16% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +16.16% |
50-Day Moving Average | 1.03 |
200-Day Moving Average | 1.33 |
Relative Strength Index (RSI) | 52.20 |
Average Volume (20 Days) | 2,895,630 |
Short Selling Information
The latest short interest is 574,938, so 3.42% of the outstanding shares have been sold short.
Short Interest | 574,938 |
Short Previous Month | 980,132 |
Short % of Shares Out | 3.42% |
Short % of Float | 4.89% |
Short Ratio (days to cover) | 1.57 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -8.02M |
Pretax Income | -12.36M |
Net Income | -7.85M |
EBITDA | n/a |
EBIT | -8.02M |
Earnings Per Share (EPS) | -$0.51 |
Full Income Statement Balance Sheet
The company has $2.83 million in cash and n/a in debt, giving a net cash position of $2.83 million or $0.17 per share.
Cash & Cash Equivalents | 2.83M |
Total Debt | n/a |
Net Cash | 2.83M |
Net Cash Per Share | $0.17 |
Equity (Book Value) | 2.20M |
Book Value Per Share | 0.13 |
Working Capital | 2.16M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -5.56M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |